Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

NCT00399763 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder
Substance Abuse

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Denver Health and Hospital Authority

Collaborators

[object Object]